155 related articles for article (PubMed ID: 34768464)
1. Albuminuria Pre-Emptively Identifies Cardiac Patients at Risk of Contrast-Induced Nephropathy.
Vicente-Vicente L; Casanova AG; Hernández-Sánchez MT; Prieto M; Martínez-Salgado C; López-Hernández FJ; Cruz-González I; Morales AI
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768464
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil Gelatinase-Associated Lipocalin as an Early Marker of Contrast-Induced Nephropathy After Elective Invasive Cardiac Procedures.
Kafkas N; Liakos C; Zoubouloglou F; Dagadaki O; Dragasis S; Makris K
Clin Cardiol; 2016 Aug; 39(8):464-70. PubMed ID: 27175937
[TBL] [Abstract][Full Text] [Related]
3. Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: a randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study).
Schilcher G; Ribitsch W; Otto R; Portugaller RH; Quehenberger F; Truschnig-Wilders M; Zweiker R; Stiegler P; Brodmann M; Weinhandl K; Horina JH
BMC Nephrol; 2011 Aug; 12():39. PubMed ID: 21849080
[TBL] [Abstract][Full Text] [Related]
4. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
[TBL] [Abstract][Full Text] [Related]
5. Designing new diagnostic systems for the early detection of tobacco-associated chronic renal damage in patients of a primary care centre in Salamanca, Spain: an observational, prospective study protocol.
Prieto M; Vicente-Vicente L; Casanova AG; Hernández-Sánchez MT; Gomez-Marcos MA; Garcia-Ortiz L; Morales AI;
BMJ Open; 2020 Mar; 10(3):e032918. PubMed ID: 32152160
[TBL] [Abstract][Full Text] [Related]
6. Plasma neutrophil gelatinase-associated lipocalin (NGAL) as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomography.
Filiopoulos V; Biblaki D; Lazarou D; Chrisis D; Fatourou M; Lafoyianni S; Vlassopoulos D
Clin Kidney J; 2013 Dec; 6(6):578-83. PubMed ID: 26069825
[TBL] [Abstract][Full Text] [Related]
7. The role of neutrophil-gelatinase-associated lipocalin in early diagnosis of contrast nephropathy.
Khatami MR; Sabbagh MR; Nikravan N; Khazaeipour Z; Boroumand MA; Sadeghian S; Davoudi B
Indian J Nephrol; 2015; 25(5):292-6. PubMed ID: 26628795
[TBL] [Abstract][Full Text] [Related]
8. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
Wang L; Pu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456
[TBL] [Abstract][Full Text] [Related]
9. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography.
Ling W; Zhaohui N; Ben H; Leyi G; Jianping L; Huili D; Jiaqi Q
Nephron Clin Pract; 2008; 108(3):c176-81. PubMed ID: 18287807
[TBL] [Abstract][Full Text] [Related]
10. Contrast Volume to Cystatin C-Based Glomerular Filtration Ratio Predicts the Risk of Contrast-Induced Nephropathy After Cardiac Catheterization.
Zhao JB; Liu Y; Wu DX; Chen JY; Duan CY; Chen SQ; Tan N
Angiology; 2017 Mar; 68(3):207-215. PubMed ID: 27166381
[TBL] [Abstract][Full Text] [Related]
11. [The value of urinary neutrophil gelatinase-associated lipocalin for early diagnosis of contrast-induced nephropathy].
You W; Qi CL; Ye F; Huang SL; Xie DJ; Wu ZM; Huang K; Chen KL; Huang TY; Chen SL
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Dec; 44(12):1024-1029. PubMed ID: 28056233
[No Abstract] [Full Text] [Related]
12. Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography.
Filiopoulos V; Biblaki D; Vlassopoulos D
Ren Fail; 2014 Jul; 36(6):979-86. PubMed ID: 24673459
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil gelatinase-associated lipocalin as an early marker of contrast-induced nephropathy after coronary angiography.
Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ
Angiology; 2014 Mar; 65(3):216-23. PubMed ID: 23378196
[TBL] [Abstract][Full Text] [Related]
14. New biomarkers defining a novel early stage of Fabry nephropathy: A diagnostic test study.
Aguiar P; Azevedo O; Pinto R; Marino J; Baker R; Cardoso C; Ducla Soares JL; Hughes D
Mol Genet Metab; 2017 Jun; 121(2):162-169. PubMed ID: 28526293
[TBL] [Abstract][Full Text] [Related]
15. N-acetylcysteine reduces urinary albumin excretion following contrast administration: evidence of biological effect.
Levin A; Pate GE; Shalansky S; Al-Shamari A; Webb JG; Buller CE; Humphries KH
Nephrol Dial Transplant; 2007 Sep; 22(9):2520-4. PubMed ID: 17557777
[TBL] [Abstract][Full Text] [Related]
16. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
Worasuwannarak S; Pornratanarangsi S
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C, but not urinary or serum NGAL, may be associated with contrast induced nephropathy after percutaneous coronary invasive procedures: A single center experience on a limited number of patients.
Cecchi E; Avveduto G; D'Alfonso MG; Terreni A; Gelera E; Caldini A; Giglioli C
Acta Med Acad; 2017 May; 46(1):34-43. PubMed ID: 28605926
[TBL] [Abstract][Full Text] [Related]
18. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
[TBL] [Abstract][Full Text] [Related]
19. Quercetin, a Promising Clinical Candidate for The Prevention of Contrast-Induced Nephropathy.
Vicente-Vicente L; González-Calle D; Casanova AG; Hernández-Sánchez MT; Prieto M; Rama-Merchán JC; Martín-Moreiras J; Martín-Herrero F; Sánchez PL; López-Hernández FJ; Cruz-González I; Morales AI
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597315
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
